Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis [PDF]
, 1991 In 11 patients with decompensated cirrhosis and deteriorating renal function, the effect of the vasoconstrictor substance 8-ornithin vasopressin (ornipressin; POR 8; Sandoz, Basel, Switzerland) on renal function, hemodynamic parameters, and humoral ...
Reither, H. +8 more
core +1 more source
Hepatic encephalopathy due to cardiac cirrhosis
Clinical Case Reports, 2023 Key Clinical Message Right‐sided heart failure, including tricuspid regurgitation (TR), can cause cardiac cirrhosis. The pathophysiology is reduced arterial perfusion and passive congestion secondary to increased systemic venous pressure.
Ryohei Ono +6 more
doaj +1 more source
Drug-related problems and dosage adjustment in patients with liver disease [PDF]
, 2012 The liver is essential for the metabolism of medicinal substances. Liver disease, especially liver cirrhosis, may lead to various pharmacokinetic and pharmacodynamic changes, predisposing patients with liver cirrhosis to adverse drug events (ADEs).
Franz, Carmen Carina
core +1 more source
Notch1 signaling in the hepatic microcirculation and chronic liver disease [PDF]
, 2013 The Notch signaling pathway is an evolutionary conserved pathway that plays essential roles during vascular development and in the regulation of normal and pathological angiogenesis in the adulthood.
Rothweiler, Sonja
core +1 more source
Hepatite vírica crónica: proposta de um protocolo para o tratamento/seguimento da cirrose.
Acta Médica Portuguesa, 2008 Cirrhosis is the terminal phase of hepatic fibrosis, that leads to impaired hepatic function and blood flow. Liver cirrhosis is the final stage of many hepatic diseases characterized by chronic cellular destruction.
Vicens Diaz-Brito +2 more
doaj +1 more source
Double blind controlled trial of D-penicillamine in patients with primary biliary cirrhosis. [PDF]
, 1985 One hundred and eighty nine patients with primary biliary cirrhosis were entered into a double blind, placebo controlled randomised trial starting in January 1978 to assess the therapeutic value of d-penicillamine 1200 mg daily.
Tygstrup, Niels +7 more
core +1 more source
Clinicodiagnostic value of functional morphological changes of intestine in encephalopathy development in cirrhosis [PDF]
Саратовский научно-медицинский журнал, 2010 The aim of the article is to study frequency and expressiveness of clinico-morphological and dysbiotic intestinal changes in cirrhosis and to estimate its interrelation with manifestations of hepatic encephalopathy. 146 patients with cirrhosis ages 20 to
V.V. Ovsyannikova, I.V. Kozlova
doaj
Vaccines, 2022 Patients with cirrhosis are vulnerable to hepatic decompensation events and death following COVID-19 infection. Therefore, primary vaccination with COVID-19 vaccines is fundamental to reducing the risk of COVID-19 related deaths in patients with ...
Bálint Drácz +7 more
doaj +1 more source
Dose adaptation of drugs in patients with liver disease [PDF]
, 2004 In my thesis I defined strategies for dosage adaptation of drugs in patients with liver disease. The major goal of the thesis was to classify antineoplastic drugs and central nervous agents according to pharmacokinetic principles (hepatic extraction and ...
Tchambaz, Lydia
core +1 more source
Comparison of Inflammatory Cytokine Levels in Hepatic and Jugular Veins of Patients with Cirrhosis
Mediators of Inflammation, 2023 Background. Systemic inflammation with elevated inflammatory cytokines is a hallmark in patients with cirrhosis and the main driver of decompensation. There is insufficient data on whether inflammatory cytokine levels differ between hepatic and jugular ...
Leonard Kaps +11 more
doaj +1 more source